In another study, Chan et al. developed a microfluidic sensor platform coated with anti-EpCAM (epithelial cell adhesion molecule) antibodies to capture bladder cancer cells from liquid samples, with the ultimate goal of enabling urine-based diagnostics [51,52]. The gene discussed is EPCAM; the disease is urinary bladder carcinoma.